Achyut Healthcare Limited (BOM:543499)
India · Delayed Price · Currency is INR 5.42
+0.04 (0.74%)
At close: Jan 23, 2026
Achyut Healthcare Revenue
Achyut Healthcare had revenue of 9.21M INR in the half year ending March 31, 2025, with 13.92% growth. This brings the company's revenue in the last twelve months to 81.29M, up 25.86% year-over-year. In the fiscal year ending March 31, 2025, Achyut Healthcare had annual revenue of 30.48M, down -50.34%.
Revenue (ttm)
81.29M
Revenue Growth
+25.86%
P/S Ratio
15.71
Revenue / Employee
11.61M
Employees
7
Market Cap
1.28B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 30.48M | -30.89M | -50.34% |
| Mar 31, 2024 | 61.37M | 34.41M | 127.66% |
| Mar 31, 2023 | 26.96M | -13.54M | -33.43% |
| Mar 31, 2022 | 40.49M | 37.77M | 1,385.01% |
| Mar 31, 2021 | 2.73M | -614.28K | -18.39% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Chemkart India | 1.93B |
| Rama Vision | 1.34B |
| Checkpoint Trends | 1.21B |
| Khemani Distributors & Marketing | 1.09B |
| VijayPD Ceutical | 1.07B |
| Dipna Pharmachem | 1.07B |
| Vaidya Sane Ayurved Laboratories | 979.90M |
| Novelix Pharmaceuticals | 849.03M |